tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sanofi (FR:SAN)
:SAN
France Market
SAN
Sanofi
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Sanofi (SAN) Stock News & Sentiment

Compare
204 Followers
Sanofi’s Innovative Approach in Type 1 Diabetes Treatment: A Clinical Study Update
Premium
Company Announcements
Sanofi’s Innovative Approach in Type 1 Diabetes Treatment: A Clinical Study Update
2d ago
SNY
Sanofi’s New Study on Lunsekimig for Chronic Rhinosinusitis: A Potential Game Changer?
Premium
Company Announcements
Sanofi’s New Study on Lunsekimig for Chronic Rhinosinusitis: A Potential Game Changer?
2d ago
SNY
Regeneron and Sanofi’s Dupilumab Study: A Potential Breakthrough in Eosinophilic Gastritis Treatment
Premium
Company Announcements
Regeneron and Sanofi’s Dupilumab Study: A Potential Breakthrough in Eosinophilic Gastritis Treatment
2d ago
SNY
REGN
Sanofi’s Phase 3 Study on Amlitelimab for Atopic Dermatitis: A Potential Game-Changer?
Premium
Company Announcements
Sanofi’s Phase 3 Study on Amlitelimab for Atopic Dermatitis: A Potential Game-Changer?
2d ago
SNY
Regeneron and Sanofi’s AROMA Study: Long-Term Insights on DUPIXENT® for CRSwNP
Premium
Company Announcements
Regeneron and Sanofi’s AROMA Study: Long-Term Insights on DUPIXENT® for CRSwNP
2d ago
SNY
REGN
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis
Premium
Company Announcements
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis
3d ago
SNY
REGN
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis
Premium
Company Announcements
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis
3d ago
SNY
REGN
More FR:SAN News >

SAN News on the Web

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Sarepta Therapeutics (SRPT)
TipRanks News
Neutral
Sanofi's SAR446597 Granted FDA Fast Track For Gene Therapy Tackling Vision Loss In AMD
rttnews
Neutral
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
CNBC
Neutral
Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), Regeneron (REGN)
TipRanks News
Neutral
Sanofi’s Phase 3 Study on Riliprubart: A Potential Game-Changer for CIDP Treatment?
TipRanks News
Neutral
Sanofi’s New Phase 2 Study: A Potential Game-Changer in Multiple Myeloma Treatment
TipRanks News
Neutral
J.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)
TipRanks News
Neutral
UBS Sticks to Their Buy Rating for Sanofi (SNYNF)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
FR:SAN
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?
2 articles about FR:SAN were published this week. In an average week, 3 articles are published.
    What is FR:SAN’s weekly average amount of articles?
    In an average week, 3 articles about FR:SAN are published.
      What is FR:SAN’s News Sentiment?
      50% of articles about FR:SAN were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        NEVIPascal Biosciences Inc
        JNJJohnson & Johnson
        HRMYHarmony Biosciences Holdings
        ABTAbbott Laboratories
        NNVCNanoViricides
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing